September 22, 2019
York Latest News | Castle Hill Deaths | Bangor Metro | Bangor Abortion | Today's Paper

Maine professor receives patent for breast cancer breakthrough

Photo courtesy of UNE
Photo courtesy of UNE
Srinidi Mohan's research focuses on a blood marker that can be used to detect the presence of highly aggressive tumors. He says the marker is a reliable indicator for estrogen receptor-negative tumors, the most aggressive types of breast cancer.

BIDDEFORD, Maine — A University of New England pharmacy professor has received a patent for an innovation in the early detection of breast cancer.

Srinidi Mohan’s research focuses on a blood marker that can be used to detect the presence of highly aggressive tumors. He says the marker is a reliable indicator for estrogen receptor-negative tumors, the most aggressive types of breast cancer.

Mohan said Wednesday the bio-marker screening could represent a cost-effective option for early detection, monitoring disease progression, measuring treatment outcomes and providing monthly check-ups.

The American Breast Cancer Foundation says about 60,000 women are diagnosed with those tumors each year. They’re most prevalent among young women and in African-American women. Chemotherapy is the common treatment for the deadly tumors.

Follow the Bangor Daily News on Facebook for the latest Maine news.

 



Have feedback? Want to know more? Send us ideas for follow-up stories.

You may also like